Skip to content

A Cohort Study of Traditional Chinese Medicine in the Treatment of Bradyarrhythmias

A Cohort Study of Traditional Chinese Medicine in the Treatment of Bradyarrhythmias

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025000313
Enrollment
Unknown
Registered
2025-02-18
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bradyarrhythmias

Interventions

Western Medicine cohort:Treatment for the underlying condition or do not intervene
Traditional Chinese Medicine cohort:Traditional Chinese medicine treatment

Sponsors

Affiliated Hospital to Changchun University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria for bradyarrhythmia in the "Guidelines" and meet one of the following conditions (1) Heart rate= 50 beats/min; (2) 50 beats/min< heart rate<60 beats/min accompanied by palpitations fatigue fatigue and other symptoms; (3) Patients diagnosed with atrioventricular block or ventricular block on resting ECG. 2. Age= 18 years old gender is not limited; 3. Voluntarily participate understand and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Patients who have had serious adverse cardiovascular events such as acute coronary syndrome Ass syndrome ventricular fibrillation etc. within 3 months; 2. Patients with sick sinus syndrome and atrioventricular block that meet the indications of permanent pacing therapy class I; 3. Secondary bradyarrhythmia caused by drug treatment and other reasons; 4. Patients with mental illness cognitive decline and other conditions that affect communication; 5. Patients with severe liver and kidney impairment (liver aminotransferase (ALT or AST) and bilirubin caused by non-cardiac reasons exceed 1.5 times the upper limit of normal value and the glomerular filtration rate is less than 15ml/min/1.73m2); 6. Patients with allergies or allergies to multiple drugs; 7. Patients who do not have access to medical information or whose information is missing; Women who are pregnant (or have a positive pregnancy test).

Design outcomes

Primary

MeasureTime frame
Change from baseline in Atrioventricular block;Change from baseline in 24-hour total heart rate;

Secondary

MeasureTime frame
Change from baseline in resting ECG indicators(Such as QT interval\PR interval);Change from baseline in bradycardia symptoms(Such as palpitation\fatigue);Change from baseline in 24-hour average heart rate;Change from baseline in slowest heart rate in 24 hours;Cardiovascular endpoint event;

Countries

China

Contacts

Public ContactJiajuan Guo

Affiliated Hospital to Changchun University of Chinese Medicine

gjj-2005@163.com15948000128

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026